What laboratory monitoring, if any, is recommended for patients starting and continuing on lebrikizumab?

Featuring James Del Rosso, DO | Clinical Advisor | Adjunct Clinical Professor (Dermatology)Touro University NevadaHenderson, NVResearch Director/ Principal Investigator/ Clinical DermatologistJDR Dermatology ResearchLas Vegas, NV | Published October 01, 2025